Low cardiac fibrosis biomarkers levels predict cardiac resynchronization therapy response
نویسندگان
چکیده
منابع مشابه
How to predict response to cardiac resynchronization therapy?
Cardiac resynchronization therapy (CRT) is considered a major breakthrough in the treatment of patients with end-stage heart failure. Initial studies demonstrated an acute improvement in haemodynamics immediately after CRT, whereas a large number of studies with midterm follow-up (6 months to 1 year) demonstrated an improvement in heart failure symptoms, quality-of-life score, exercise capacity...
متن کاملCardiac sympathetic reserve and response to cardiac resynchronization therapy.
BACKGROUND The objective of the present study was to investigate the effect of cardiac resynchronization therapy (CRT) on cardiac autonomic function. METHODS AND RESULTS This prospective study included 45 consecutive patients with heart failure who received CRT devices with defibrillator and 20 age-matched, healthy control subjects. At baseline and 3 months and 6 months after CRT, we assessed...
متن کاملCardiac-resynchronization therapy.
Cardiac resynchronization therapy (CRT) addresses abnormal left ventricular (LV) activation that produces detrimental effects on cardiac systolic and diastolic function. CRT improves symptoms and ventricular performance, promotes reverse remodeling, and decreases mortality and hospitalization in patients with congestive heart failure (CHF). Atrial-synchronized biventricular stimulation reverses...
متن کاملCardiac Resynchronization Therapy
According to the 2013 update on heart disease statistics from American Heart Association, an estimated 5.1 million Americans ≥20 years of age have a diagnosis of heart failure. In the year 2009, heart failure was noted to be the primary cause of death in >56 000 people and contributed to death of >274 000 people. It is one of the most common causes of hospitalization in patients ≥65 years of ag...
متن کامل[Cardiac resynchronization therapy].
Fifteen years after the birth of resynchronization therapy, this technique has become one of the recommended treatments in severe heart failure patients, with low ejection fraction (4 35%), and conduction disorders (ORS > or = 120 ms). Based on large randomized clinical trials, the European recommendation is class I type (level of evidence A), to improve symptoms and survival of this patient po...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Archives of Cardiovascular Diseases Supplements
سال: 2018
ISSN: 1878-6480
DOI: 10.1016/j.acvdsp.2017.11.255